These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1517684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y.
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
    Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY, Appelman H.
    J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Zinc therapy induction of intestinal metallothionein in Wilson's disease.
    Brewer GJ.
    Am J Gastroenterol; 1999 Feb; 94(2):301-2. PubMed ID: 10022620
    [No Abstract] [Full Text] [Related]

  • 8. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
    McQuaid A, Lamand M, Mason J.
    J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M, Percl M, Jadresin O, Kolacek S.
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
    Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ.
    Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
    Nartey NO, Frei JV, Cherian MG.
    Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
    [Abstract] [Full Text] [Related]

  • 19. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L, Sturniolo GC, Giacon G, Montino MC, Lecis PE, Schade RR, Corazza GR, Trevisan C, Naccarato R.
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.
    Lee DY, Brewer GJ, Wang YX.
    J Lab Clin Med; 1989 Dec; 114(6):639-45. PubMed ID: 2592854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.